期刊文献+

静脉用药中的微粒污染对微循环的影响

暂未订购
导出
摘要 在临床治疗中,特别在应用大量及多种静脉药物的重症监护领域,医疗质量的控制和病人的安全性极其重要。由于仿制药物的生产及应用不断扩大,带来了静脉用药中的微粒污染问题,甚至可导致毒性作用而危及病人安全。因此有必要对静脉微粒污染的产生机制、病理生理、临床危害、控制方法等进行研究。本文综合了临床与实验研究的资料,对微粒污染所导致的微循环影响进行综述。
作者 吕婕
出处 《临床儿科杂志》 CAS CSCD 北大核心 2000年第5期309-310,共2页 Journal of Clinical Pediatrics
  • 相关文献

参考文献13

  • 1Kirkpatrick CJ, Lehr HA, Bittinger F, et al. Clinical implications of circulating particulate contamination of parenteral injections. Crit Care & Shock, 1999,4: 166.
  • 2Robinson LA, Braimbridge MV, Herse DJ. The potential hazard of particulate contamination of cardioplegic solution. J Thorac Cardiovasc Surg, 1984. 87: 48.
  • 3Fujishita O, Sendo T, Hisazumi A, et al. The evaluation of sizing accuracy of partiale counter for parenteral drug. PUD J Pharmaceut Sci Technol, 1995, 49: 267.
  • 4Wetterich U. Mutschler E. Quality of cefotaxime sodium preparations. Drug Res, 1995, 45: 74.
  • 5Di Paolo ER, Hirschi B, Pannatier A. Quantitative determination of particulate contamination in intravenous administration sets.Pharm Weekbl [Sci], 1990 Oct. 19,12(5) : 190.
  • 6Backhouse CM, Ball PR, Booth S, et al. Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol, 1987, 39 : 241.
  • 7Kirkpartrick CJ, Bittinger F, Klein CL, et al. The role of the microcirculation in multiple organ dysfunction syndrome (MODS):a review and perspective. Virchows Arch, 1996, 427 : 461.
  • 8Riede UN, Joachim H, Hassenstein J, et al. The pulmonary airblood barrier of human shock lungs. (a clinical, ultrastructural and morphometric study). Pathol Res Pract, 1978, 162: 41.
  • 9Blauth C, Arnold J, Kohner EM, et al. Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet, 1986, ii: 837.
  • 10Shaw PJ. The incidence and nature of neurological morbidity following cardiac surgery : a review. Perfusion, 1989, 4 : 83.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部